Thin and in situ melanomas of unfavorable prognosis: A retrospective observational analysis of local recurrence, metastasis, and death in early-stage disease - 06/11/24
Doi : 10.1016/j.jaad.2024.09.057
Joao Renato V. Gontijo, MD, MSc a, b, c, Jacob H. Nelson, DO c, Kyra Diehl, BS c, Veselina B. Korcheva, MD c, d, Flavia Vasques Bittencourt, MD, PhD a, Sancy A. Leachman, MD, PhD c, ⁎ 
a Dermatology Unit, Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
b Dermatology Unit, Hospital Mater Dei, Belo Horizonte, Brazil
c Department of Dermatology, Oregon Health and Science University, Portland, Oregon
d Providence Portland Medical Center, Portland, Oregon
∗Correspondence to: Sancy A. Leachman, MD, PhD, Department of Dermatology, 3303 S Bond Ave, Ste 16D, Portland, OR 97239Department of Dermatology3303 S Bond AveSte 16DPortlandOR97239
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Wednesday 06 November 2024
Key words : early detection, melanoma, metastasis, overdiagnosis, prognosis, recurrence, skin neoplasms
| Funding sources: Tissue, data, and salary resources provided by the OHSU Department of Dermatology and Dermatopathology along with the Dermatology Unit, Faculdade de Medicina da Universidade Federal de Minas Gerais. |
|
| Patient consent: No identifiable material, including photographs or identifiable medical information, is included in this manuscript. All included data are de-identified, and as such, this manuscript has been determined to be exempt by the IRB. |
|
| IRB approval status: Reviewed by Oregon Health and Science University IRB and determined to be not human research (Request #18166). Reviewed and approved by Universidade Federal de Minas Gerais IRB, approval #4458601. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?